The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

9 May 2019 07:00

RNS Number : 4419Y
Highlands Natural Resources PLC
09 May 2019
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

9 May 2019

 

Highlands Natural Resources plc

("Highlands" or the "Company")

 

Trading Update

 

Highlands, the London-listed natural resources company, is pleased to provide the following trading update on the progress at its East Denver project and Zoetic Organics ("Zoetic").

 

East Denver

 

Combined oil production from the eight producing wells is currently approximately 2,700 Bopd and combined gas production is currently approximately 4,000 Mcfpd. Highlands' operating partner continues to proceed with its conservative production strategy. Five of the new wells are being operated on a limited choke size of 25/64th inch with the sixth well at 29/64th inch.

The limited choke size is based on a considered methodology focused on maintaining well pressure and extending the well lives. It is anticipated that the chokes will be opened further in the coming weeks with the objective of maintaining a steady production at around 10% above current levels.

Notwithstanding the current flow rates, Highlands' 7.5% carried interest in the project is generating monthly revenue in excess of the Company's fixed operating costs (which includes expense items such as office costs, payroll and professional fees). Highlands also incurs certain variable and discretionary expenditure in relation to the operation of its other projects but the Company is developing two additional revenue streams: the sale of nitrogen in Kansas in conjunction with a local partner and imminent retail sales of a range of CBD (the naturally occurring compound found in the cannabis flower) products by Zoetic, the Company's wholly owned subsidiary, as described in more detail below.

Taking account of the expected revenues from these additional sources (but before the revenues from Zoetic's crops as described below), the Board remains of the view that the Company will generate sufficient cash flow to cover all overheads for the current year.

Zoetic Organics

 

Zoetic has been advancing its retail strategy for its Zoetic-branded CBD products. First deliveries manufactured from the current operations will be made to Schrader Oil convenience stores this month. This means that initial revenues will be recognised in June.

Zoetic has also established its own direct-to-retail website and further details will be announced when sales on that site go live. Highlands and Zoetic continue to actively develop new products and identify further sales and distribution channels, including other specialist stores, and Zoetic will continue to source the raw materials from Colorado wholesalers pending its own production.

Planting of hemp outdoors is now underway. Having refined its plans since the previous investor update in March 2019, the Zoetic team is proposing to plant two eight-acre fields. The planting density, the ability to sell the non-flower parts of the plant as biomass and current flower prices means that the revenue potential for Zoetic's outdoor crops this year is estimated to be an improvement on the previous plan.

Management considers the deadline for planting this year's crop to be 30 June 2019 but anticipates finishing its work well before that date.

Management also plans to deliver an additional revenue stream to this business, having evolved its strategy for plants at its 33,000 sq ft greenhouse. In addition to growing plants for CBD production exclusively, Zoetic also intends to produce feminised hemp seeds for sale to other hemp producers.

The greenhouse's capacity is up to 10,000 plants per season and a well-managed plant has the potential to produce in excess of 500 seeds. Whilst the growing cycle for seed production is marginally longer, management believe that not less than three seasons per annum is achievable. The Zoetic management team believes that the controlled conditions in the greenhouse, and the supply of Highlands' proprietary nitrogen-hydrogen gaseous fertiliser, has the potential to establish a robust seed-production operation. This provides Zoetic with a growth opportunity materially in excess of the previous plan outlined to investors. Zoetic's management team is currently working on the most suitable strains of hemp for seed production.

Demand for high quality seeds is very strong as the hemp and CBD industries continue to expand, and it is not unusual for the most sought after seeds to retail at up to $1 each. Seed producers do typically incur costs associated with laboratory testing, storage, seed-broker fees and quality control initiatives and Highlands has factored these into Zoetic's business plan.

A seed production strategy has a timing implication on revenue. Growers typically do not purchase seeds until planting time and so, whilst Zoetic's seed production can be carried out all year-round, revenue will be weighted towards the last quarter of Highlands' financial year.

Robert Price, Executive Chairman and CEO of Highlands, said: "The progress made by Zoetic since we established this operation less than two months ago has been excellent. From a standing start, we have three revenue lines underway within the Zoetic business and I look forward to providing further updates as our retail sales develop. This is a fast-moving industry but the combination of our facilities and innovative management team has enabled us to take a flexible approach which I am confident will deliver good returns to our shareholders in the years to come. In the meantime, our East Denver project is being operated to the highest standards and providing regular revenue to Highlands."

 

 

**ENDS**

 

Enquiries

 

Highlands Natural Resources plc +1 (0) 303 322 1066

Robert Price

Nick Tulloch

 

Cantor Fitzgerald Europe +44 (0) 20 7894 7000

David Porter

Newgate Communications +44 (0) 20 3757 6880

Elisabeth Cowell

Fiona Norman

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBVLLBKEFLBBE
Date   Source Headline
16th Aug 20217:00 amRNSChange of Name
3rd Aug 20214:00 pmRNSNotice of Results
30th Jul 20213:30 pmRNSHolding(s) in Company
29th Jul 20217:00 amRNSBusiness Update
8th Jul 20212:05 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSBusiness Update
7th Jun 20214:40 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSIssue of Warrants
28th May 20215:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSUpdate on ‘Chill’ orders
4th May 20217:00 amRNSSubscription raises £6m, LDA financing cancelled
30th Apr 20215:00 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSTrading Update
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20217:00 amRNSNovel Food Application
31st Mar 20215:00 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSIssue of Shares
25th Mar 20217:00 amRNSExercise of Share Options
15th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20219:06 amRNSSecond Price Monitoring Extn
9th Mar 20219:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSFinancing Agreement with LDA Capital
8th Mar 20212:45 pmRNSHolding(s) in Company
2nd Mar 20213:00 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSUS Distribution Update
15th Feb 20217:00 amRNSProgress Update
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSInterim Results
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
8th Jan 20217:00 amRNSCommencement of trading on the OTCQX
31st Dec 20207:00 amRNSUpdate on Sale of DTU
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20202:05 pmRNSSecond Price Monitoring Extn
16th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20206:00 pmRNSHolding(s) in Company
10th Dec 20206:00 pmRNSHolding(s) in Company
9th Dec 202010:00 amRNSHolding(s) in Company
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
30th Nov 20205:00 pmRNSTotal Voting Rights
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.